Great-West Lifeco Inc. (TSX:GWO)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48,314	44,419	40,882	29,166	35,322	28,157
Market Cap Growth	29.95%	8.65%	40.17%	-17.43%	25.45%	-8.86%
Enterprise Value	53,807	50,452	48,753	36,502	43,234	37,598
PE Ratio	12.67	11.27	14.93	8.11	11.29	9.57
PS Ratio	1.39	1.28	1.31	0.96	0.55	0.46
PB Ratio	1.46	1.36	1.37	1.01	1.16	1.04
P/OCF Ratio	11.16	9.35	8.47	7.73	3.41	2.93
EV/Sales Ratio	1.54	1.45	1.56	1.20	0.67	0.62
EV/EBITDA Ratio	5.58	5.14	6.41	4.54	9.12	9.56
EV/EBIT Ratio	5.93	5.42	6.82	4.81	10.09	10.55
Debt / Equity Ratio	0.29	0.44	0.44	0.39	0.32	0.40
Debt / EBITDA Ratio	0.99	1.45	1.71	1.39	2.02	2.67
Quick Ratio	30.04	25.38	21.22	13.25	12.57	13.02
Current Ratio	34.07	29.02	24.86	15.23	14.96	15.84
Asset Turnover	0.05	0.05	0.05	0.05	0.11	0.12
Return on Equity (ROE)	12.87%	13.58%	10.28%	12.38%	12.39%	12.00%
Return on Assets (ROA)	0.74%	0.77%	0.65%	0.73%	0.43%	0.42%
Return on Capital (ROIC)	13.86%	12.94%	10.77%	11.82%	6.87%	6.34%
Earnings Yield	7.95%	9.16%	7.02%	12.78%	9.23%	10.93%
Earnings Yield	7.95%	9.16%	7.02%	12.78%	9.23%	10.93%
Dividend Yield	4.69%	4.77%	5.10%	7.10%	5.71%	7.30%
Payout Ratio	56.65%	54.03%	72.07%	52.50%	55.52%	57.18%
Buyback Yield / Dilution	-0.10%	-0.17%	-0.13%	-0.14%	-0.34%	1.98%
Total Shareholder Return	4.59%	4.60%	4.97%	6.96%	5.37%	9.28%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.